期刊文献+

亲属活体肾移植的临床分析和移植肾组织病理分析 被引量:3

Clinical and histopathological analysis in living donor kidney transplantation recipients
原文传递
导出
摘要 目的 总结亲属活体肾移植后移植肾组织活检资料,并结合临床进行回顾性分析。方法亲属活体肾移植55例,其中有血缘的亲属供肾移植53例,夫妻间供肾移植2例。供、受者间HLA配型,1条单倍型相同者45例,2条单倍型相同者6例,5个抗原错配者3例,完全错配者1例。除1例采用腹腔镜取肾外,其余均采取开放手术取肾。供肾热缺血时间1~8min,冷缺血时间1~2h。术后应用环孢素A(或他克莫司)、硫唑嘌呤(或霉酚酸酯)及泼尼松预防排斥反应。结果 55例中,有10例接受16次移植肾活检,结果 4例次为急性排斥反应(Banff分级均为Ⅰ级),3例次经甲泼尼龙冲击治疗逆转,1例合并慢性移植肾肾病,治疗无效,恢复透析;3例次为移植肾退行性病变(其中2例合并急性环孢素A肾毒性损伤),2例减少环孢素A用量,并加用西罗莫司,效果良好,1例将环孢素A转换为西罗莫司,效果不佳,恢复透析;4例次为急性肾小管坏死,采用他克莫司和霉酚酸酯联合用药,并辅以透析治疗,肾功能恢复正常。结论 虽然亲属活体肾移植术后急性排斥反应和移植肾功能恢复延迟的发生率低,但仍应重视术后移植肾组织活检,将被动活检转为主动的计划性活检,以提高亚临床排斥反应的检出率。 Objective To make a retrospective analysis of kidney allograft biopsy combined with clinical data in living donor kidney transplantation (LDKT) recipients. Methods Fifty-five patients within whom 53 cases donated by living-related donors and 2 cases by spouse underwent LDKT. As to HLA matching, 45 cases shared one haplotype, 6 cases shared two haplotypes, Ⅰ fully mismatch and the other 3 with 5-coli mismatch. Except one donor underwent laparoscopic nephrectomy, the others underwent open nephrectomy. Warm ischemia time of grafts varied from one min to 8 min, and cold ischemia time one h to 2 h. Triple-combined immunosuppressive regimes included calcineurin inhibitors (CNI) such as cyclosporine or tacrolimus, anti-proliferative agents as azathioporine or mycophenolate mofetil and costisteroid. Results Ten recipients (male 8, female 2) underwent allograft biopsy for 16 times. Acute rejection fAR) episodes (grade 1, banff classification) appeared in 4 patients within which 3 cases being reversed by high intravenous dose of methylprednisolone, but the other one lost kidney graft. Evidence of chronic retrogressive nephropathy of donor kidneys was detected in 3 cases in which 2 patients gained long-term graft survival through reduction of CNI combined with sirolimus (SRL), and acute tubular necrosis (ATN) appeared in 2 cases. Conclusions In living donor kidney transplant, the role of allograft biopsy is considerable even with low incidence of AIR episodes and delayed graft function. Programmed biopsy is preferable to make early diagnosis of subclinical acute rejection.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2006年第5期274-276,共3页 Chinese Journal of Organ Transplantation
基金 国家自然科学基金资助项目(30200263)
关键词 肾移植 活体供者 活组织检查 针吸 Kidney transplantation Living donors Biopsy, needle
  • 相关文献

参考文献5

  • 1Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology.
  • 2Working Party of the British Transplantation Society and the Renal Association. United Kingdom Guidelines for living donor kidney transplantation. London: British Transplantation Society, 2000. 1-82.
  • 3刘斌,明长生,曾凡军,林正斌,陈知水,张伟杰,陈实.移植肾肾功能延迟恢复受者免疫抑制治疗方案的研究[J].医学临床研究,2003,20(10):756-759. 被引量:5
  • 4Mctaggart RA, Gottlieb D, Brooks J, et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant, 2003, 3:416.
  • 5Chueh SCJ, Kahan BD. Clinical application of sirolimus in renal transplantation: an update. Transplant Int, 2005, 18:261 277.

二级参考文献8

  • 1刘斌 陈实.钙神经素抑制剂他克莫司作用机制的新认识[A].见:陈实主编.移植学前沿[C].武汉:湖北科技出版社,2002.235-237.
  • 2Cecka JM, Shoskes DA, Gjertson DW, et al . Clinical impact of delayed graft function for kidney transplantation [J].Transplant Rev , 2001, 15(2):57.
  • 3Ojo AO, Wolfe RA, Held PJ, et al . Delayed graft function:Risk factors and implications for renal allograft survival[J].Transplantation , 1997, 63:968.
  • 4Johnson C, Ahsan N, Gonwa T, et al. Randomized trial of tacrolimus (Tacrolimus) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation[J].Transplantation , 2000, 69:834.
  • 5Miller J, Mendez R, Pirsch JD, et al . Safety and efficacy of tacro limus in combination with mycophenolate mofetil (MMF)in cadaveric renal transplant recipients[J]. Transplantation ,2000, 69:875.
  • 6Ahsan N,Johnson C,Gonwa T, et al . Randomized trial of tacrolimus plus myeophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus myeophenolate mofetil after cadaveric kidney transplantation: results at 2 years[J].Transplantation , 2001, 72: 245-250.
  • 7Laskow DA, Vincenti F, Neylan JF, et al . An open-labelled,concentration ranging of FKS06 in primary kidney transplantation: a report of the united states muhicenter FKS06 kidney transplant group[J]. Transplantation , 1996,62(7):900.
  • 8王立明,闵志廉,朱有华,高春芳,陆慧琦,周梅生,姚亚成.肾移植受者FK506治疗窗浓度的临床观察[J].肾脏病与透析肾移植杂志,2000,9(3):237-239. 被引量:12

共引文献4

同被引文献19

  • 1曾凡军,刘斌,蒋继贫,张伟杰,林正斌,陈知水,明长生,朱兰,陈忠华.亲属活体肾移植101例分析[J].中华器官移植杂志,2006,27(5):265-267. 被引量:66
  • 2金昊,昌盛.亲属活体肾移植的发展和现状[J].中华器官移植杂志,2006,27(5):318-320. 被引量:35
  • 3Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int, 2000,57 : 307- 313.
  • 4Moritz M, Halpern E, Mitchell D, et al. Comparison of CT and MR angiography for evaluation of living renal donors. Transplant Proc, 2001,33:831-832.
  • 5Delmonieo F. A report of the Amsterdam forum on the Care of the live kidney donor: data and medical guidelines. Transplantation,2005, 79:53-66.
  • 6Soulillou JP. Risks and benefits to the living donor. N Engl J Med, 2005,353:447-449.
  • 7Knight RJ, Burrows L, Bodian C. The influence of acute rejection on long-term renal allograft survival:a comparison of living and cadaveric donor transplantation. Transplantation,2001,72:69-76.
  • 8Kirste G. Living-donor kidney transplantation. Langenbecks Arch Surg, 1999,384:523-527.
  • 9Ratner LE, Kavoussi LR, Schulam PG, et al. Comparison of laparoscopic live donor nephrectomy versus the standard openapproach. Transplant Proc, 1997, 29 : 138-139.
  • 10Nogueira JM, Cangro CB, Fink JC, et al. A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. Transplantation, 1999, 67:722-725.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部